{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:22:56Z","timestamp":1790673776815,"version":"4.1.0"},"reference-count":86,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01EY026479"],"award-info":[{"award-number":["R01EY026479"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DP160100011"],"award-info":[{"award-number":["DP160100011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["R01EY026479"],"award-info":[{"award-number":["R01EY026479"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP160100011"],"award-info":[{"award-number":["DP160100011"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research to Prevent Blindness","award":["R01EY026479"],"award-info":[{"award-number":["R01EY026479"]}]},{"name":"Research to Prevent Blindness","award":["DP160100011"],"award-info":[{"award-number":["DP160100011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>There is a significant unmet need for therapeutics to treat ocular surface barrier damage, also called epitheliopathy, due to dry eye and related diseases. We recently reported that the natural tear glycoprotein CLU (clusterin), a molecular chaperone and matrix metalloproteinase inhibitor, seals and heals epitheliopathy in mice subjected to desiccating stress in a model of aqueous-deficient\/evaporative dry eye. Here we investigated CLU sealing using a second model with features of ophthalmic preservative-induced dry eye. The ocular surface was stressed by topical application of the ophthalmic preservative benzalkonium chloride (BAC). Then eyes were treated with CLU and sealing was evaluated immediately by quantification of clinical dye uptake. A commercial recombinant form of human CLU (rhCLU), as well as an rhCLU form produced in our laboratory, designed to be compatible with U.S. Food and Drug Administration guidelines on current Good Manufacturing Practices (cGMP), were as effective as natural plasma-derived human CLU (pCLU) in sealing the damaged ocular surface barrier. In contrast, two other proteins found in tears: TIMP1 and LCN1 (tear lipocalin), exhibited no sealing activity. The efficacy and selectivity of rhCLU for sealing of the damaged ocular surface epithelial barrier suggests that it could be of therapeutic value in treating BAC-induced epitheliopathy and related diseases.<\/jats:p>","DOI":"10.3390\/ijms24020981","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:12:15Z","timestamp":1672888335000},"page":"981","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recombinant Human Clusterin Seals Damage to the Ocular Surface Barrier in a Mouse Model of Ophthalmic Preservative-Induced Epitheliopathy"],"prefix":"10.3390","volume":"24","author":[{"given":"Shravan K.","family":"Chintala","sequence":"first","affiliation":[{"name":"USC Institute for Genetic Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Pan","sequence":"additional","affiliation":[{"name":"New England Eye Center, Tufts Medical Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1479-1280","authenticated-orcid":false,"given":"Sandeep","family":"Satapathy","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong, Wollongong, NSW 2522, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Condruti","sequence":"additional","affiliation":[{"name":"Training Program in Cell, Molecular and Developmental Biology, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Hao","sequence":"additional","affiliation":[{"name":"Training Program in Pharmacology and Drug Development, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-wen","family":"Liu","sequence":"additional","affiliation":[{"name":"Training Program in Pharmacology and Drug Development, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"O\u2019Conner","sequence":"additional","affiliation":[{"name":"Doctor of Medicine Training Program, Tufts University School of Medicine, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Barr","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Optometry, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Wilson","sequence":"additional","affiliation":[{"name":"School of Chemistry and Molecular Bioscience, Molecular Horizons Research Institute, University of Wollongong, Wollongong, NSW 2522, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinwu","family":"Jeong","sequence":"additional","affiliation":[{"name":"USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elizabeth","family":"Fini","sequence":"additional","affiliation":[{"name":"New England Eye Center, Tufts Medical Center, Department of Ophthalmology, Tufts University School of Medicine, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1167\/iovs.07-0770","article-title":"The ocular surface: The challenge to enable and protect vision: The Friedenwald lecture","volume":"48","author":"Gipson","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archopht.1960.01840010538009","article-title":"Cell production and migration in the epithelial layer of the cornea","volume":"64","author":"Hanna","year":"1960","journal-title":"Arch. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archopht.1961.01840020697016","article-title":"Cell turnover in the adult human eye","volume":"65","author":"Hanna","year":"1961","journal-title":"Arch. Ophthalmol."},{"key":"ref_4","first-page":"44","article-title":"Managing ocular surface disease: A common-sense approach","volume":"29","author":"Ong","year":"2016","journal-title":"Community Eye Health"},{"key":"ref_5","unstructured":"TFOS (2007). Report of the International Dry Eye Workshop (DEWS). Ocul. Surf., 5, 65\u2013204."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/IIO.0000000000000169","article-title":"What We Have Learned From Animal Models of Dry Eye","volume":"57","author":"Stern","year":"2017","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Tsubota, K., Pflugfelder, S.C., Liu, Z., Baudouin, C., Kim, H.M., Messmer, E.M., Kruse, F., Liang, L., Carreno-Galeano, J.T., and Rolando, M. (2020). Defining Dry Eye from a Clinical Perspective. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239271"},{"key":"ref_9","first-page":"CD010051","article-title":"Topical cyclosporine A therapy for dry eye syndrome","volume":"9","author":"Pflugfelder","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1080\/03007995.2016.1210107","article-title":"Lifitegrast clinical efficacy for treatment of signs and symptoms of dry eye disease across three randomized controlled trials","volume":"32","author":"Holland","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","article-title":"Lifitegrast, a Novel Integrin Antagonist for Treatment of Dry Eye Disease","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul. Surf."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ophtha.2016.09.025","article-title":"Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3)","volume":"124","author":"Holland","year":"2017","journal-title":"Ophthalmology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exer.2016.04.019","article-title":"Clusterin in the eye: An old dog with new tricks at the ocular surface","volume":"147","author":"Fini","year":"2016","journal-title":"Exp. Eye Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101032","DOI":"10.1016\/j.preteyeres.2021.101032","article-title":"Clusterin, other extracellular chaperones, and eye disease","volume":"89","author":"Wilson","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/aja.2013.38","article-title":"Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer","volume":"15","author":"Toren","year":"2013","journal-title":"Asian J. Androl."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1158\/0008-5472.CAN-13-0359","article-title":"Cotargeting Androgen Receptor and Clusterin Delays Castrate-Resistant Prostate Cancer Progression by Inhibiting Adaptive Stress Response and AR Stability","volume":"73","author":"Matsumoto","year":"2013","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbrc.2007.02.148","article-title":"Clusterin is protective in pancreatitis through anti-apoptotic and anti-inflammatory properties","volume":"356","author":"Savkovic","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bj3280045","article-title":"Stress-induced transcription of the clusterin\/apoJ gene","volume":"328","author":"Michel","year":"1997","journal-title":"Biochem. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/15216540310001640498","article-title":"Small heat-shock proteins and clusterin: Intra- and extracellular molecular chaperones with a common mechanism of action and function?","volume":"55","author":"Carver","year":"2003","journal-title":"IUBMB Life"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1074\/jbc.274.11.6875","article-title":"Clusterin has chaperone-like activity similar to that of small heat shock proteins","volume":"274","author":"Humphreys","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"21920","DOI":"10.1074\/jbc.M109.033688","article-title":"Structural characterization of clusterin-chaperone client protein complexes","volume":"284","author":"Wyatt","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1021\/bi991581b","article-title":"pH-dependent changes in the in vitro ligand-binding properties and structure of human clusterin","volume":"39","author":"Hochgrebe","year":"2000","journal-title":"Biochemistry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-biochem-072711-163904","article-title":"Extracellular chaperones and proteostasis","volume":"82","author":"Wyatt","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0968-0004(99)01534-0","article-title":"Clusterin is a secreted mammalian chaperone","volume":"25","author":"Wilson","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ajpath.2012.01.025","article-title":"Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation","volume":"180","author":"Jeong","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9440(10)62232-8","article-title":"Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye","volume":"166","author":"Pflugfelder","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1016\/S0021-9258(18)77299-2","article-title":"Purification and characterization of apolipoprotein J","volume":"265","author":"Stuart","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1016\/S0021-9258(18)99123-4","article-title":"Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma","volume":"266","author":"Jenne","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/bj3310231","article-title":"Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: A potential anti-atherogenic function?","volume":"331","author":"Gelissen","year":"1998","journal-title":"Biochem. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1073\/pnas.90.2.725","article-title":"Apolipoprotein J expression at fluid-tissue interfaces: Potential role in barrier cytoprotection","volume":"90","author":"Aronow","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1021\/acschemneuro.0c00637","article-title":"Apolipoprotein J in Alzheimer;s Disease: Shedding Light on Its Role with Cell Signaling Pathway Perspective and Possible Therapeutic Approaches","volume":"11","author":"Moezzi","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"166384","DOI":"10.1016\/j.bbadis.2022.166384","article-title":"Clusterin in Alzheimer;s disease: An amyloidogenic inhibitor of amyloid formation?","volume":"1868","author":"Spatharas","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rivas-Urbina, A., Rull, A., Aldana-Ramos, J., Santos, D., Puig, N., Farre-Cabrerizo, N., Benitez, S., Perez, A., de Gonzalo-Calvo, D., and Escola-Gil, J.C. (2020). Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113-122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice. Biomolecules, 10.","DOI":"10.3390\/biom10060829"},{"key":"ref_34","first-page":"158541","article-title":"Low-density lipoprotein aggregation is inhibited by apolipoprotein J-derived mimetic peptide D-[113-122]apoJ","volume":"1865","author":"Rull","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.18632\/aging.103310","article-title":"Clusterin exerts a cytoprotective and antioxidant effect in human osteoarthritic cartilage","volume":"12","author":"Tarquini","year":"2020","journal-title":"Aging"},{"key":"ref_36","first-page":"1800","article-title":"A gene expression profile of human corneal epithelium and the isolation of human keratin 12 cDNA","volume":"37","author":"Nishida","year":"1996","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_37","first-page":"1702","article-title":"Changes in conjunctival clusterin expression in severe ocular surface disease","volume":"43","author":"Nakamura","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1021\/pr0501970","article-title":"Characterization of human tear proteome using multiple proteomic analysis techniques","volume":"4","author":"Li","year":"2005","journal-title":"J. Proteome Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.exer.2013.05.020","article-title":"Lacritin and the tear proteome as natural replacement therapy for dry eye","volume":"117","author":"Karnati","year":"2013","journal-title":"Exp. Eye Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/j.jprot.2012.04.053","article-title":"In-depth analysis of the human tear proteome","volume":"75","author":"Zhou","year":"2012","journal-title":"J. Proteom."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jtos.2018.08.001","article-title":"Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results","volume":"16","author":"Yu","year":"2018","journal-title":"Ocul. Surf."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Bauskar, A., Mack, W.J., Mauris, J., Argueso, P., Heur, M., Nagel, B.A., Kolar, G.R., Gleave, M.E., Nakamura, T., and Kinoshita, S. (2015). Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138958"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Fini, M.E., Jeong, S., and Wilson, M.R. (2020). Therapeutic Potential of the Molecular Chaperone and Matrix Metalloproteinase Inhibitor Clusterin for Dry Eye. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010116"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: The good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_46","unstructured":"U.S. Food and Drug Administration (2022, November 08). Facts About the Current Good Manufacturing Practices (CGMPs), Available online: https:\/\/www.fda.gov\/drugs\/pharmaceutical-quality-resources\/facts-about-current-good-manufacturing-practices-cgmps."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-022X(00)00137-8","article-title":"An antigen capture assay for the measurement of serum clusterin concentrations","volume":"48","author":"Morrissey","year":"2001","journal-title":"J. Biochem. Biophys. Methods"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"14243","DOI":"10.1038\/s41598-020-70990-3","article-title":"Rapid high-yield expression and purification of fully post-translationally modified recombinant clusterin and mutants","volume":"10","author":"Satapathy","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/pro.5560061007","article-title":"Identification and characterization of glycosylation sites in human serum clusterin","volume":"6","author":"Kapron","year":"1997","journal-title":"Protein Sci. A Publ. Protein Soc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41551-018-0259-1","article-title":"Point-of-care production of therapeutic proteins of good-manufacturing-practice quality","volume":"2","author":"Adiga","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e1800397","DOI":"10.1002\/biot.201800397","article-title":"Affinity Chromatography: An Enabling Technology for Large-Scale Bioprocessing","volume":"15","author":"Lacki","year":"2020","journal-title":"Biotechnol. J."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Dabbs, R.A., and Wilson, M.R. (2014). Expression and purification of chaperone-active recombinant clusterin. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086989"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/ICO.0000000000000893","article-title":"Tear Matrix Metalloproteinases and Myeloperoxidase Levels in Patients With Boston Keratoprosthesis Type I","volume":"35","author":"Robert","year":"2016","journal-title":"Cornea"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1167\/iovs.02-0766","article-title":"Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis","volume":"44","author":"Leonardi","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1542-0124(11)70022-2","article-title":"Tear lipocalin: Structure and function","volume":"9","author":"Dartt","year":"2011","journal-title":"Ocul. Surf."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/bjo.2004.055822","article-title":"Decreased tear lipocalin concentration in patients with meibomian gland dysfunction","volume":"89","author":"Yamada","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/128_2011_262","article-title":"Extracellular chaperones","volume":"328","author":"Dabbs","year":"2013","journal-title":"Top. Curr. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"DES163","DOI":"10.1167\/iovs.17-23402","article-title":"Potential Role of Oxidative Stress in Ocular Surface Inflammation and Dry Eye Disease","volume":"59","author":"Dogru","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1167\/iovs.09-3774","article-title":"Protective effect of clusterin from oxidative stress-induced apoptosis in human retinal pigment epithelial cells","volume":"51","author":"Kim","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2110-5820-3-4","article-title":"Specific antioxidant properties of human serum albumin","volume":"3","author":"Taverna","year":"2013","journal-title":"Ann. Intensive Care"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1389557520666200807132617","article-title":"A Review on Vitamin E Natural Analogues and on the Design of Synthetic Vitamin E Derivatives as Cytoprotective Agents","volume":"21","author":"Papagiouvannis","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1167\/iovs.07-0430","article-title":"Functions of MUC16 in corneal epithelial cells","volume":"48","author":"Blalock","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"23037","DOI":"10.1074\/jbc.M109.033332","article-title":"Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier","volume":"284","author":"Argueso","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/jcp.24398","article-title":"The cellular mechanisms of dry eye: From pathogenesis to treatment","volume":"228","author":"Mantelli","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1167\/iovs.07-0720","article-title":"A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride","volume":"49","author":"Xiong","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_66","first-page":"257","article-title":"A mouse dry eye model induced by topical administration of benzalkonium chloride","volume":"17","author":"Lin","year":"2011","journal-title":"Mol. Vis."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Yang, Q., Zhang, Y., Liu, X., Wang, N., Song, Z., and Wu, K. (2017). A Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL\/6 and BALB\/c Mice. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030509"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.59.11.667","article-title":"Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man","volume":"59","author":"Wilson","year":"1975","journal-title":"Br. J. Ophthalmol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.preteyeres.2014.10.001","article-title":"Clinical staining of the ocular surface: Mechanisms and interpretations","volume":"44","author":"Bron","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1167\/iovs.10-6489","article-title":"Fluorescein punctate staining traced to superficial corneal epithelial cells by impression cytology and confocal microscopy","volume":"52","author":"Mokhtarzadeh","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jtos.2019.11.006","article-title":"Dose-dependent benzalkonium chloride toxicity imparts ocular surface epithelial changes with features of dry eye disease","volume":"18","author":"Zhang","year":"2020","journal-title":"Ocul. Surf."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clae.2013.11.003","article-title":"Fluorescein staining and physiological state of corneal epithelial cells","volume":"37","author":"Bandamwar","year":"2014","journal-title":"Contact Lens Anterior Eye J. Br. Contact Lens Assoc."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Bakkar, M.M., Hardaker, L., March, P., Morgan, P.B., Maldonado-Codina, C., and Dobson, C.B. (2014). The cellular basis for biocide-induced fluorescein hyperfluorescence in mammalian cell culture. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084427"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Webster, A., Chintala, S.K., Kim, J., Ngan, M., Itakura, T., Panjwani, N., Argueso, P., Barr, J.T., Jeong, S., and Fini, M.E. (2018). Dynasore protects the ocular surface against damaging oxidative stress. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204288"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/archopht.1992.01080190090035","article-title":"What is actually stained by rose bengal?","volume":"110","author":"Feenstra","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0161-6420(92)31947-5","article-title":"Comparison of fluorescein and rose bengal staining","volume":"99","author":"Feenstra","year":"1992","journal-title":"Ophthalmology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.bbamem.2011.04.003","article-title":"Relationship between membrane permeability and specificity of human secretory phospholipase A(2) isoforms during cell death","volume":"1808","author":"Nelson","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/prot.340080202","article-title":"Amphipathic helix motif: Classes and properties","volume":"8","author":"Segrest","year":"1990","journal-title":"Proteins"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1517\/13543784.15.1.13","article-title":"Oral amphipathic peptides as therapeutic agents","volume":"15","author":"Reddy","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jps.23761","article-title":"Trends in translational medicine and drug targeting and delivery: New insights on an old concept-targeted drug delivery with antibody-drug conjugates for cancers","volume":"103","author":"Ho","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref_81","first-page":"309","article-title":"Biologic agents in inflammatory eye disease","volume":"6","author":"Posarelli","year":"2011","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/17425247.2016.1227783","article-title":"Recent perspectives on the delivery of biologics to back of the eye","volume":"14","author":"Joseph","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-4939-6412-3_8","article-title":"Tagging Recombinant Proteins to Enhance Solubility and Aid Purification","volume":"1485","author":"Loughran","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/02713683.2020.1801758","article-title":"Gender-Specific Differences in Signs and Symptoms of Dry Eye Disease","volume":"46","author":"Borrelli","year":"2021","journal-title":"Curr. Eye Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","article-title":"TFOS DEWS II Sex, Gender, and Hormones Report","volume":"15","author":"Sullivan","year":"2017","journal-title":"Ocul. Surf."},{"key":"ref_86","first-page":"632","article-title":"A mouse model of keratoconjunctivitis sicca","volume":"43","author":"Dursun","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/981\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:59:08Z","timestamp":1760119148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":86,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24020981"],"URL":"https:\/\/doi.org\/10.3390\/ijms24020981","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}